With 1.46 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.74 million shares. The 52-week range on CRI shows that it touched its highest point at $72.11 and its lowest point at $32.04 during that stretch. It currently has a 1-year price target of $29.00. With its current market cap of 1.19 billion, CRI has annualized dividend of $3.20 while the current yield stands at 9.76%. Beta for the stock currently stands at 1.03.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CRI was down-trending over the past week, with a drop of -3.30%, but this was down by -11.83% over a month. Three-month performance dropped to -35.98% while six-month performance fell -40.07%. The stock lost -52.83% in the past year, while it has lost -39.51% so far this year. A look at the trailing 12-month EPS for CRI yields 4.52 with Next year EPS estimates of 2.52. For the next quarter, that number is 0.34. This implies an EPS growth rate of -43.20% for this year and -23.54% for next year. EPS is expected to decline by -23.80% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -2.63%.
Float and Shares Shorts:
At present, 36.24 million CRI shares are outstanding with a float of 35.00 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CRI since 2 analysts follow the stock currently. There are 0 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 1 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $5.39411 being high and $5.20954 being low. For CRI, this leads to a yearly average estimate of $5.32212.
